Eating Disorders News and Research

Latest Eating Disorders News and Research

Pfizer reports Progression-Free survival in SUN 1087 combination trial of sunitinib with erlotinib for NSCLC

Pfizer Inc. announced today that the SUN 1087 trial of sunitinib in combination with erlotinib versus erlotinib demonstrated a statistically significant improvement in Progression-Free but not in Overall Survival in patients with previously treated advanced non-small cell lung cancer (NSCLC).

24 Aug 2010

Muscle mass plays key role in cancer survival: Research

In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood. Now, researchers reporting in the August 20 issue of Cell, a Cell Press Publication, have found some new clues and a way to reverse that process in mice. What's more, animals with cancer that received the experimental treatment lived significantly longer, even as their tumors continued to grow.

20 Aug 2010

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

Sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved a new one-vial formulation of its chemotherapeutic agent Taxotere® (docetaxel) Injection Concentrate. The 1-vial Taxotere is anticipated to become available to cancer treatment clinics and hospitals nationwide in the fall in both 80 mg and 20 mg dosages.

5 Aug 2010

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studies in patients with chronic hepatitis C virus (HCV) genotype 1 infection, the addition of boceprevir to treatment with PEGINTRON® and REBETOL® significantly increased the number of patients who achieved sustained virologic response, compared to control groups that received Peg/riba plus placebo.

5 Aug 2010

Tips for healthy eating at college

For college students, the campus dining hall offers a tantalizing feast: ice-cream sundaes every night, thirty varieties of cereal and a limitless supply of french fries."It's like a smorgasborg on a cruise ship," said Cynthia Bulik, PhD, director of the Eating Disorders Program at the UNC School of Medicine. All-you-can-eat dining halls, along with changes in exercise habits, have been blamed for the "freshman 15," in which first-year students gain weight.

5 Aug 2010

$Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released$

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Millennium: The Takeda Oncology Company today reported new correlative science data from the pivotal PINNACLE trial of VELCADE (bortezomib) in patients with relapsed/refractory mantle cell lymphoma. The data, derived from an analysis of archived tumor samples, tested pre-specified biomarkers for their association with time to progression and response to treatment with VELCADE in patients with relapsed MCL.

30 Jul 2010

Increased SIRT1 protein can delay delay aging, extend lifespan

Researchers watched two groups of mice, both nearing the end of a two-day fast. One group was quietly huddled together, but the other group was active and alert. The difference? The second set of mice had been engineered so their brains produced more SIRT1, a protein known to play a role in aging and longevity.

29 Jul 2010

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus infection to peginterferon alpha-based therapy.

28 Jul 2010

FDA approves Aricept 23 mg tablet for Alzheimer's disease

Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept 23 mg tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom few treatments are available

26 Jul 2010

Four areas that impact weight, obesity in women identified

The information gap and general lack of understanding of obesity's unique and disproportionate impact on women contributes to the challenges of the 65 million American women who are considered overweight or obese, said the Strategies to Overcome and Prevent (STOP) Obesity Alliance Task Force on Women at a meeting on Capitol Hill today.

22 Jul 2010

Active family engagement is important for recovery from substance abuse, chemical dependency

Active family engagement and commitment is one of the most underappreciated aspects of recovery from substance abuse and chemical dependency, according to clinical staff at Timberline Knolls Residential Treatment Center, a leading eating disorder and addiction treatment center.

16 Jul 2010

Deaths from heroin overdoses in Chicago's Cook County fall 16%: Study

A new study by Roosevelt University's Illinois Consortium on Drug Policy shows deaths from heroin overdoses in Chicago's Cook County fell 16 percent during the last decade, but the Chicago metropolitan region still ranks among the worst in the nation for heroin use. Kimberly Dennis, M.D., eating disorder specialist at Chicago's Timberline Knolls Residential Treatment Center, sees the use of heroin regularly from women and girls she treats and knows the importance of awareness and seeking help to overcome this addiction.

12 Jul 2010

Fussy eating may be an “eating disorder” say researchers

Picky and fussy eaters are not just being difficult to please say U.S. researchers. They may be suffering from an eating disorder like anorexia or bulimia. Soon the disorder is to have an official name and the American Psychiatric Association plans to call them “selective eaters”.

11 Jul 2010

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

7 Jul 2010

Virtual food can be used for evaluation and treatment of eating disorders: Researchers

Food presented in a virtual reality environment causes the same emotional responses as real food. Researchers writing in BioMed Central's open access journal Annals of General Psychiatry compared the responses of people with anorexia and bulimia, and a control group, to the virtual and real-life snacks, suggesting that virtual food can be used for the evaluation and treatment of eating disorders.

5 Jul 2010

Web sites that promote anorexia raise concern

For women with low self-esteem, poor body image and a certain genetic predisposition towards an eating disorder, the messages promoted on pro-eating disorder web sites can be similar to someone considering suicide finding a loaded gun on her pillow.

3 Jul 2010

Fera Pharmaceuticals launches Neptazanetm tablets for reducing intraocular pressure

Fera Pharmaceuticals is pleased to announce the launch of Neptazane (Methazolamide) 25 mg and 50 mg tablets. Both strengths are available in 90 count bottles.

3 Jul 2010

Elements Behavioral Health acquires The Ranch in Tennessee

Elements Behavioral Health, provider of residential treatment services for addiction and co-occurring disorders, announced this week the acquisition of The Ranch in Nunnelly, Tennessee. Elements is best known to the public as the owner of the internationally famous Promises Treatment Centers in Malibu and Los Angeles, where many Hollywood celebrities have been treated successfully for substance abuse.

2 Jul 2010

Women in early recovery gain new perspective on helping themselves by helping others

Women seeking to overcome an eating disorder or addiction still face numerous hurdles once they acknowledge their disease and commit to pursuing a path of recovery. Women with advanced or multiple interconnected diseases often seek inpatient or residential treatment, which gives them time to step back from the demands of daily life to focus solely on themselves.

1 Jul 2010

Majority of older women seek help for eating disorders

Eating disorders are equal-opportunity offenders – crossing economic and cultural boundaries and leaping the borders of age and gender. For a long time thought to be diseases affecting teens and young women in their 20s, eating disorder treatment centers nationwide are seeing an increase in the population of older women seeking help for eating disorders.

25 Jun 2010

Eating Disorders News and Research

Latest Eating Disorders News and Research

Pfizer reports Progression-Free survival in SUN 1087 combination trial of sunitinib with erlotinib for NSCLC

Muscle mass plays key role in cancer survival: Research

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Tips for healthy eating at college

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Increased SIRT1 protein can delay delay aging, extend lifespan

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

FDA approves Aricept 23 mg tablet for Alzheimer's disease

Four areas that impact weight, obesity in women identified

Active family engagement is important for recovery from substance abuse, chemical dependency

Deaths from heroin overdoses in Chicago's Cook County fall 16%: Study

Fussy eating may be an “eating disorder” say researchers

Shire receives FDA approval of Daytrana for ADHD in adolescents

Virtual food can be used for evaluation and treatment of eating disorders: Researchers

Web sites that promote anorexia raise concern

Fera Pharmaceuticals launches Neptazanetm tablets for reducing intraocular pressure

Elements Behavioral Health acquires The Ranch in Tennessee

Women in early recovery gain new perspective on helping themselves by helping others

Majority of older women seek help for eating disorders

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eating Disorders News and Research

Latest Eating Disorders News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in